These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32562808)
1. Left ventricular dysfunction in COVID-19: A diagnostic issue. Jacquet-Lagrèze M; Riad Z; Hugon-Vallet E; Ferraris A; Fellahi JL Anaesth Crit Care Pain Med; 2020 Jun; 39(3):393-394. PubMed ID: 32562808 [No Abstract] [Full Text] [Related]
2. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217 [No Abstract] [Full Text] [Related]
3. COVID-19 and QT interval prolongation: more than just drug toxicity? Merino JL; Martínez-Cossiani M; Iniesta A; Escobar C; Rey JR; Castrejón-Castrejón S Europace; 2020 Oct; 22(10):1479. PubMed ID: 32441761 [No Abstract] [Full Text] [Related]
4. Emerging cardiological issues during the COVID-19 pandemic. Everaert BR; Muylle J; Bartholomeus Twickler T Eur J Clin Invest; 2020 Jul; 50(7):e13270. PubMed ID: 32415992 [No Abstract] [Full Text] [Related]
5. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366 [TBL] [Abstract][Full Text] [Related]
6. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin. Anupama BK; Adhikari S; Chaudhuri D J Investig Med High Impact Case Rep; 2020; 8():2324709620948407. PubMed ID: 32762368 [TBL] [Abstract][Full Text] [Related]
7. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval. Samuel S; Friedman RA; Sharma C; Ganigara M; Mitchell E; Schleien C; Blaufox AD Heart Rhythm; 2020 Nov; 17(11):1960-1966. PubMed ID: 32621881 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 associated viral myocarditis: does it exist? Verma V; Sondhi S; Sharma R; Mahajan K Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32945641 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients? Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872 [No Abstract] [Full Text] [Related]
10. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Pani A; Lauriola M; Romandini A; Scaglione F Int J Antimicrob Agents; 2020 Aug; 56(2):106053. PubMed ID: 32534189 [TBL] [Abstract][Full Text] [Related]
11. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. Roden DM; Harrington RA; Poppas A; Russo AM Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703 [No Abstract] [Full Text] [Related]
12. [Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence]. Mele D; D'Andrea A; Campana M; Di Giannuario G; Flamigni F; Gimelli A; Khoury G; Rizzo M; Moreo A G Ital Cardiol (Rome); 2020 Oct; 21(10):739-749. PubMed ID: 32968306 [TBL] [Abstract][Full Text] [Related]
13. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine]. Tomcsányi J; Tomcsányi K Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19. Horowitz NA; Brenner B Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920 [No Abstract] [Full Text] [Related]
15. First Documentation of Persistent SARS-Cov-2 Infection Presenting With Late Acute Severe Myocarditis. Pavon AG; Meier D; Samim D; Rotzinger DC; Fournier S; Marquis P; Monney P; Muller O; Schwitter J Can J Cardiol; 2020 Aug; 36(8):1326.e5-1326.e7. PubMed ID: 32522523 [TBL] [Abstract][Full Text] [Related]
16. Acute meningoencephalitis in a patient with COVID-19. Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534 [No Abstract] [Full Text] [Related]
17. Cardiac considerations in patients with COVID-19. Calvillo-Argüelles O; Ross HJ CMAJ; 2020 Jun; 192(23):E630. PubMed ID: 32357998 [No Abstract] [Full Text] [Related]
19. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks. Yahya AS; Khawaja S; Chukwuma J Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496 [No Abstract] [Full Text] [Related]
20. Current data on the cardiovascular effects of COVID-19. Vlachakis PK; Tentolouris A; Tousoulis D; Tentolouris N Hellenic J Cardiol; 2020; 61(1):46-48. PubMed ID: 32315757 [No Abstract] [Full Text] [Related] [Next] [New Search]